Peijia Medical Advances Global Expansion with EU MDR CE Mark Filing for GeminiOne TEER System

Peijia Medical Limited announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application fo...

February 10, 2026 | Tuesday | News
Eisai’s Leqembi Autoinjector Clears Key Regulatory Step in China for Early Alzheimer’s Treatment

BioArctic AB's (publ) (NASDAQ: BIOA B (Stockholm: BIOA B) partner Eisai announced  that the Biologics License Application (BLA) for the treatme...

February 10, 2026 | Tuesday | News
Ascentage Pharma Strengthens Hematologic Cancer Pipeline with Global Clinical Advancement of APG-3288

Ascentage Pharma Group International , a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commerc...

February 09, 2026 | Monday | News
Promega Secures NMPA Approval for OncoMate® MSI Detection Kit as Companion Diagnostic for KEYTRUDA® in China

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro...

February 05, 2026 | Thursday | News
AstraZeneca Deepens Weight Management Push With $1.2B AI-Driven Obesity Deal With CSPC

Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovati...

February 03, 2026 | Tuesday | News
Baoting Launches World’s First County-Level “Living Laboratory” to Advance 1.5°C Proactive Health Standards

Baoting Establishes World's First County-Level "Living Laboratory," Developing 1.5°C Proactive Health Standards  Breaking with decades of capit...

February 03, 2026 | Tuesday | News
Tenacia and Golden Age Health Partner to Commercialize First-Ever Approved Treatment for CDD in China

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform Tenacia Biopharmaceutical...

February 02, 2026 | Monday | News
China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne

China’s National Medical Products Administration (NMPA) has approved Seysara®(sarecycline hydrochloride) for the treatment of inflammatory ...

January 30, 2026 | Friday | News
Argo Biopharma and Novartis Dose First Patient in Phase 2b Trial of siRNA Therapy BW-20829

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, announ...

January 27, 2026 | Tuesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Ant Group Upgrades AQ Health Assistant With DeepSearch to Support Evidence-Based Clinical Decision-Making

Ant Group  announced a major upgrade to the PC platform of its AI-native health assistant, AQ, introducing DeepSearch for clinicians, a new capabili...

January 22, 2026 | Thursday | News
China Approves Sanofi’s Myqorzo and Redemplo for Cardiovascular and Rare Metabolic Diseases

Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome Underscores Sanofi’s long-ter...

January 16, 2026 | Friday | News
ElpasBio Partners With Fosun Kairos to Commercialize AlloJoin® Stem Cell Therapy for Knee Osteoarthritis in Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a col...

January 15, 2026 | Thursday | News
Nxera Pharma Secures APAC Rights to Vamorolone for Duchenne Muscular Dystrophy

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and China New...

January 09, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close